According to the recent study the biopharmaceutical fermentation system marketis projected to grow at a CAGR of 6%-8% from 2020 to 2025. Growth in this market is primarily driven byincreasing the demand for biotech based drugs and rising research and development activities to produce novel biological drugs.
Browse XX figures / charts and XXtables in this 150 -page report to understand trends, opportunities and forecast in biopharmaceutical fermentation systemmarketby product (upstream products [fermenters, bioprocess analyzers, process monitoring devices, culture and media preparation, culture media, buffers and inducers, and other upstream products] and downstream products [filtration and separation systems, chromatography, consumables and accessories, and other downstream products]), application (recombinant proteins, monoclonal antibodies, antibiotics, and probiotics), end use (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, and food industry), and region (North America, Europe, Asia Pacific, and Rest of the World).
“Downstream product market is expected to remain the largest segment during the forecast period.”
Based on product, the biopharmaceutical fermentation systemmarket is segmented intoupstream products [fermenters, bioprocess analyzers, process monitoring devices, culture and media preparation, culture media, buffers and inducers, and other upstream products] and downstream products [filtration and separation systems, chromatography, consumables and accessories, and other downstream products]. Lucintel forecasts thatthe downstream products is expected to witness the largest segment over the forecast period.
“Within the biopharmaceutical fermentation systemmarket, the recombinant proteins segment is expected to remain the largest application”
Based on application, the recombinant proteins segment is expected to witness the largest application over the forecast period due to high reliance on microbial system for recombinant protein production, increased investment in research activities and the introduction of new protein, and development of recombinant therapeutic antibodies and proteins.
“Asia Pacificwill dominate the biopharmaceutical fermentation systemmarket in near future”
Asia Pacificis expected to be the largest region over the forecast perioddue to well established healthcare infrastructure, presence of key players, and rising industrialization in the region.
